| Income Statement for Acorda Therapeutics Inc. (ACOR) | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | | | Operating Revenue | 39,486 | 27,351 | 5,146 | 479 | | Adjustments to Revenue | - | - | - | - | | Cost of Revenue | (9,011) | (5,540) | (3,320) | (2,232) | | Gross Operating Profit | 30,475 | 21,811 | 1,825 | (1,753) | | | Selling/General/Admin Expense | (48,167) | (31,640) | (21,533) | (17,945) | | Research & Development | (22,410) | (12,055) | (12,890) | (21,999) | | EBITDA | (40,102) | (21,884) | (32,598) | (41,697) | | Depreciation & Amortization | 655 | (1,583) | (1,812) | (3,070) | | EBIT | (39,447) | (23,467) | (34,410) | (44,767) | | Interest Income | 4,087 | 1,471 | 402 | 409 | | Other Income, Net | 51 | 75 | 1 | 2 | | Total Income Avail For Interest Expense | (35,310) | (21,920) | (34,007) | (44,355) | | Interest Expense | (2,664) | (2,553) | (1,526) | (385) | | Pre-Tax Income | (37,974) | (24,474) | (35,533) | (44,741) | | Income Taxes | - | - | - | - | | Minority Interest | - | - | - | - | | Net Income from Continuing Operations | (37,974) | (24,474) | (35,533) | (44,741) | | Net Income from Discontinued Operations | - | - | - | - | | Net Income from Total Operations | (37,974) | (24,474) | (35,533) | (44,741) | | | Normalized Income | (37,974) | (24,474) | (35,533) | (44,741) | | Extraordinary Income | - | - | - | - | | Special Income/Charges | - | - | - | - | | Income from Cum. Effect of Acct Change | - | 454 | 3 | - | | Income from Tax Loss Carryforward | - | - | - | - | | Other Gains | - | - | - | - | | Total Net Income | (37,974) | (24,019) | (35,530) | (44,741) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | 36,007 | 24,849 | 24,746 | | | Basic EPS from Continuing Operations | -1.45 | -3.27 | -295.27 | -351.76 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | -1.45 | -3.27 | -295.27 | -351.76 | | | Diluted EPS from Continuing Operations | -1.45 | -3.27 | -295.27 | -351.76 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | -1.45 | -3.27 | -295.27 | -351.76 | | | |
